It has been previously established that the epidermis in SSc patients undergoes critical changes, including a proposed model of TGF-β-induced activation of epithelial cells, causing an epithelial-to-mesenchymal transition (EMT)-like phenomena and resulting in the hallmark damaging and pathogenic fibrosis of the disease [19]. This evidence concerns the gene TGFB1 and systemic sclerosis.